Investing

The investment landscape is constantly evolving, compelling investors to seek timely information to make informed decisions. “Stocks @ Night,” a daily newsletter, serves to encapsulate the most relevant stock market information, steering investors toward the opportunities and challenges awaiting them. As we reviewed recent trading activity, a mixture of optimism and caution defined the market
0 Comments
In a noteworthy financial maneuver, Acurx Pharmaceuticals recently announced its board’s approval for the purchase of up to $1 million worth of bitcoin, marking a significant shift in its treasury management strategy. This decision arrives amid a landscape where cryptocurrencies are steadily gaining traction as legitimate assets for corporate reserves. While the company’s stock has
0 Comments
Cathie Wood’s ARK Innovation exchange-traded fund (ETF) has recently stirred conversations in the investment community, especially following its significant decline from its pandemic peak. In a candid appearance on CNBC’s “Squawk Box,” Wood described her fund as inherently volatile, emphasizing that it should serve as a “satellite strategy” rather than a substantial portion of any
0 Comments
The investment landscape can often feel unstable, especially in periods of economic transition following major political events, such as elections. Lately, the post-election rally has been marred by fluctuations that have caused uncertainty among investors. Amid these turbulent times, savvy investors can find valuable opportunities if they maintain a focus on long-term potential rather than
0 Comments
On a recent Friday, the stock market witnessed a significant decline in processed food companies, largely stemming from investor apprehensions regarding new political leadership under President-elect Donald Trump and his close associate, Robert F. Kennedy Jr. This unrest in the market exemplifies how closely intertwined politics and market stability can be. Notable players in the
0 Comments
BlackRock has taken a significant step in the evolving landscape of finance by expanding its tokenized money market fund. The USD Institutional Digital Liquidity Fund, known as BUIDL, is now accessible to investors across multiple blockchains, including Aptos, Arbitrum, Avalanche, OP Mainnet (formerly known as Optimism), and Polygon. This expansion marks a pivotal moment in
0 Comments
In recent years, the financial markets have experienced a whirlwind of speculation regarding the impact of presidential elections on hedge fund performance. However, a closer examination of data spanning back to 1991 suggests that the assumption of a higher hedge fund return under Republican leadership does not hold true. According to Hedge Fund Research (HFR),
0 Comments
As the financial world processes the implications of President-elect Donald Trump’s pro-business stance, experts like Jeremy Siegel from the Wharton School bring significant insights into potential market dynamics. Siegel, in a recent discussion on CNBC, characterized Trump as “the most pro-stock market president we have had in our history.” This assertion stems from Trump’s historical
0 Comments
In the fast-paced world of biopharmaceuticals, few companies symbolize the potential for growth and innovation as strikingly as Verona Pharma. Founded in 2005 and headquartered in London, this clinical-stage biopharmaceutical firm is on the threshold of a significant breakthrough, engaging in the development and commercialization of therapies for respiratory diseases that are in critical need
0 Comments